Cannimed Therapeutics Inc (CMED.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMED.TO | GLAS-A-U.NE | CL.CN | ||
| Company | Cannimed Therapeutics Inc | Glass House Brands Inc Subordinate Shares | Cresco Labs Inc | ||
| Price Information | |||||
| Exchange | TSX | Cboe CA | CNSX | ||
| Open | 28.50 | 9.0000 | 1.7000 | ||
| High | 28.50 | 9.2900 | 1.7900 | ||
| Low | 27.00 | 8.7600 | 1.5700 | ||
| Latest | 27.00 | 8.7600 | 1.6000 | ||
| Change | -1.50 | -0.2400 | -0.1400 | ||
| % Change | -5.26% | -2.67% | -8.05% | ||
| Volume | 52,208 | 37,651 | 379,199 | ||
| 20-Day Average Volume | 57,223 | 174,780 | 665,720 | ||
| Previous Close | 28.50 | 9.0000 | 1.7400 | ||
| Industry | TSX Drug Specialty & Generic | N/A | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 31.14 | 7.6545 | 1.4957 | ||
| 20-Day Raw Stochastic | 0.00% | 71.00% | 28.64% | ||
| 20-Day Relative Strength | 37.45 | 57.92 | 51.18 | ||
| Weighted Alpha | +162.80 | +9.66 | -50.59 | ||
| Today's Opinion | N/A | 88% Buy | 72% Buy | ||
| Previous Opinion | N/A | 88% Buy | 56% Buy | ||
| Last Month's Opinion | N/A | 8% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.36% since 04/24/18 | -3.63% since 12/18/25 | -1.84% since 12/18/25 | ||
| Low | 27.00 on 05/01/18 | 8.7600 on 12/29/25 | 1.5200 on 12/23/25 | ||
| High | 32.48 on 04/25/18 | 10.0100 on 12/19/25 | 2.0600 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | -25.46% since 03/29/18 | +49.74% since 11/28/25 | +52.38% since 11/28/25 | ||
| Low | 27.00 on 05/01/18 | 5.7300 on 12/11/25 | 0.9900 on 12/09/25 | ||
| High | 36.40 on 04/02/18 | 10.0100 on 12/19/25 | 3.1200 on 12/18/25 | ||
| 3-Month | |||||
| %Chg | -10.00% since 02/01/18 | +8.42% since 09/29/25 | -14.89% since 09/29/25 | ||
| Low | 23.38 on 02/05/18 | 5.0300 on 11/19/25 | 0.8900 on 11/19/25 | ||
| High | 41.00 on 03/07/18 | 10.0100 on 12/19/25 | 3.1200 on 12/18/25 | ||
| 6-Month | |||||
| %Chg | +109.79% since 11/01/17 | +55.60% since 06/27/25 | +131.88% since 06/27/25 | ||
| Low | 12.54 on 11/02/17 | 4.5400 on 07/15/25 | 0.6500 on 07/03/25 | ||
| High | 46.00 on 01/24/18 | 10.0100 on 12/19/25 | 3.1200 on 12/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 668,430 | 722,334 | 621,902 | ||
| Shares Outstanding, K | 24,757 | 77,486 | 357,415 | ||
| Annual Sales | 0 | 200,898,000 | 724,343,000 | ||
| Annual Net Income | 0 | 519,000 | -74,438,000 | ||
| Last Quarter Sales | N/A | 38,444,000 | 164,913,000 | ||
| Last Quarter Net Income | N/A | -12,294,000 | -17,054,000 | ||
| 60-Month Beta | N/A | 0.83 | 1.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 | -0.19 on 11/12/25 | -0.05 on 11/07/25 | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 158.82 | N/A | N/A | ||